Optical Genome Mapping Market Poised to Witness High Growth Due to Rising Investments in Genomics

Optical genome mapping is an advanced technique used for genome assembly and helps in mapping large genomic rearrangements. It provides a physical genome map of a cell that helps researchers analyze its structure, including things like DNA inversions, translocations and other complex variants. Optical mapping has applications in various fields including cancer research, precision medicine, clinical diagnostics, and agricultural research.

The global optical genome mapping market size is estimated to be valued at US$ 109.9 million in 2024 and is expected to exhibit a CAGR of 21% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the optical genome mapping market are Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, and Cerba.

Key opportunities in the market include increasing adoption of Optical Genome Mapping Market by various academic and research institutes owing to its advantages over next generation sequencing. Optical mapping helps address limitations of sequencing by providing long-range structural information.

Global expansion is also being witnessed in the optical genome mapping market with key players focusing on regions like Asia Pacific and Europe through partnerships and new product launches. For instance, in 2021 Bionano Genomics launched its Saphyr systems and reagents in major European markets to drive adoption of optical genome mapping.

Market Drivers

Increasing investments by governments and private players in genomic research is a major factor driving the growth of the optical genome mapping market. Various national-level genome mapping projects underway are also boosting adoption of technologies like optical genome mapping. Growing application of genome mapping in clinics for diagnosing rare diseases and personalized medicine is another key driver.

Market Restraints

High setup and operational costs associated with optical genome mapping systems is a key challenge hampering widespread adoption. Optical mapping also requires specialized infrastructure, protocols and trained personnel limiting its use to core genomic research facilities currently. Issues related to data analysis and lack of standardization also pose restrain to optical genome mapping market.

Segment Analysis

The global optical genome mapping market can be segmented based on product into instruments, kits & reagents, software and services. Among these, the instruments segment dominated the market in 2024. The high cost of instruments is a key factor contributing to the large market share of this segment. The development of advanced and high throughput instruments at lower prices by key players is expected to drive the growth of this segment during the forecast period.

The services segment is expected to grow at the highest CAGR from 2024 to 2031. Increasing application of optical genome mapping in fields such as synthetic biology, molecular diagnostics, genomics, and epigenomics is driving the demand for services such as data analysis, cloud computing solutions, and research activities. Additionally, rising awareness about genetic disorders and availability of government and private funding for research projects are also supporting the growth of the services segment.

Global Analysis

On the basis of region, North America held the largest share of the global optical genome mapping market in 2024. This can be primarily attributed to the growing focus on clinical and research-based genomic studies, rising demand for personalized medicines, and developing healthcare infrastructure in the region. Asia Pacific market is projected to expand at the highest CAGR over the forecast period. Increasing healthcare expenditure, improving diagnostic capabilities, and expanding operations of leading market players are supporting the growth of the optical genome mapping market in Asia Pacific. Meanwhile, Europe also represents a significant market share due to the presence of major pharmaceutical and biotechnology companies and growing application areas of optical genome mapping in oncology and reproductive health research.

Get more insights on Optical Genome Mapping Market